News

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...
Scientists are probing woolly mammoth and Neanderthal genetic codes for new compounds as today’s drugs lose potency.
The researchers focused on CymAKp, a dynamic porin found in Klebsiella pneumoniae, a WHO-listed high-priority pathogen. Using ...
U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...
Microalgae of the species Monoraphidium contortum have the ability to remove antibiotic residues from water, especially ...
WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech”, "Kane” or the "Company”) ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...
The British drugmaker may have succeeded in reviving an oral antibiotic previously rejected by the FDA when it was under ...
Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...
Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...
RGCB have discovered innovative methods to tackle bacterial resistance to antibiotics, a growing global health threat. Their approach targets porins in bacterial outer membranes. This collaborative ...